Por: RTTNews Health September 27, 2023
Viatris Inc. () and Ocuphire Pharma, Inc. () announced the FDA has approved RYZUMVI 0.75% for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists or parasympatholytic agents. RYZUMVl is anticipated to be commercially available in the U.S. in the first half of 2024.Viatris Eye Care Division President Jeffrey Nau said: We look forward to launching RYZUMVI in the first half of next year, and to continuing to advance... + full article
RTTNews USA Health September 05, 2023
Viatris Inc. () announced FDA tentative approval for a New Drug Application for abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension for the treatment of HIV-1 infection in paediatric patients. Abacavir/dolutegravir/lamivudine is a fixed-dose combination... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Tuesday, March 28 | Orlando Sentinel
Newsweek USA Life August 10, 2023
Painkiller is a new dramatic retelling of the opioid epidemic that ravaged America—but which characters are real and which were created for dramatic effect?All six episodes of the new limited series are available to watch on Netflix now. The show stars the likes of Matthew... + más
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
ABC News USA Nation May 19, 2023
An additional person has died in an and more people are reporting they've lost their vision.The number of deaths has risen to four, according to an issued by the Centers for Disease Control and Prevention on Friday and first reported by ABC News.At least one of the deaths... + más
Here's what you need to know about the flurry of eye drop recalls | CBS News
RTTNews USA Health April 11, 2023
Some of the healthcare sector stocks that we recently featured on our site touched new highs yesterday. Were you one of the savvy investors who had them in your portfolio?1. Aldeyra Therapeutics Inc. ()Published price: $4.55 Max. Return: 127% in 9 monthsAldeyra is a... + más
Goldman Sachs just dropped the names of its biggest partner class since David Solomon took over as CEO. See the full list here. | Business Insider
These Stocks Hit New 52-Week Highs Yesterday | RTTNews
New York Daily News USA Nation February 23, 2023
The Food and Drug Administration is adding to a list of eyecare products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs. The FDA is “warning consumers and health care... + más
ABC News USA Life February 04, 2023
Two types of artificial tears eye drops have been voluntarily recalled following 55 reports of adverse use effects, including eye infections, vision loss and even a bloodstream infection that led to one death, according to federal officials.The affected eye drops were... + más
Eye drops recalled after 55 reports of bacterial infection, 1 death in 12 states | ABC7
EzriCare recalls artificial tear drops after reports of vision loss and 1 death | CBS News
Forbes USA Business November 12, 2022
As I suspect that many have limited exposure to small- and mid-cap stocks, we’ve updated our special report, Small Companies, Big Potential. Mid-Cap Value Stocks are AttractiveKovitz We also offer a reminder of the methodology we utilize for all our value-based equity... + más
As The 2022-23 NHL Season Opens, Teams Set New Standards For Salary-Cap Precision | Forbes
Europe's gas price cap leaves some nations dismayed, saying it's far too high | CNBC
About iurex | Privacy Policy | Disclaimer |